BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Diagnosis
386 results:

  • 1. Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of pancreatic Carcinomas: In Search of Therapeutic Targets.
    Faber EB; Krause HB; Amin K; Walker P; Hosein PJ; Shields AF; Lenz HJ; Prakash A; Goel S; Oberley M; Malleo G; Luchini C; Hwang J; Florou V; Garrido-Laguna I; Lou E
    JCO Precis Oncol; 2024 May; 8():e2300595. PubMed ID: 38723231
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comparing oncologic and surgical outcomes of robotic and laparoscopic pancreatoduodenectomy in patients with pancreatic cancer: a propensity-matched analysis.
    Wehrle CJ; Chang JH; Gross AR; Woo K; Naples R; Stackhouse KA; Dahdaleh F; Augustin T; Joyce D; Simon R; Walsh RM; Naffouje SA
    Surg Endosc; 2024 May; 38(5):2602-2610. PubMed ID: 38498210
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Liquid Biopsy for pancreatic cancer by Serum Extracellular Vesicle-Encapsulated Long Noncoding RNA HEVEPA.
    Takahashi K; Inuzuka T; Shimizu Y; Sawamoto K; Taniue K; Ono Y; Asai F; Koyama K; Sato H; Kawabata H; Iwamoto H; Yamakita K; Kitano Y; Teramoto T; Fujiya M; Fujii S; Mizukami Y; Okumura T
    Pancreas; 2024 May; 53(5):e395-e404. PubMed ID: 38416857
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pancreas-related persisting sequelae in ALL survivors with a history of asparaginase-associated pancreatitis: A part of the ALL-STAR study.
    Skipper MT; Birkebæk N; Jensen RB; Rank CU; Tuckuviene R; Wehner PS; Lambine TL; Hørlyck A; Schmiegelow K; Frandsen TL; Andrés-Jensen L; Albertsen BK
    Eur J Haematol; 2024 Jun; 112(6):944-956. PubMed ID: 38351310
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The relationship between DNA mismatch repair gene and other prognostic parameters in pancreatic adenocarcinoma.
    Urganci N; Kepil N; Ergun S; Bakkaloglu OK
    J Surg Oncol; 2024 Apr; 129(5):876-884. PubMed ID: 38173349
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MR Fingerprinting for Contrast Agent-free and Quantitative Characterization of Focal Liver Lesions.
    Fujita S; Sano K; Cruz G; Velasco C; Kawasaki H; Fukumura Y; Yoneyama M; Suzuki A; Yamamoto K; Morita Y; Arai T; Fukunaga I; Uchida W; Kamagata K; Abe O; Kuwatsuru R; Saiura A; Ikejima K; Botnar R; Prieto C; Aoki S
    Radiol Imaging Cancer; 2023 Nov; 5(6):e230036. PubMed ID: 37999629
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Society of Critical Care Medicine and the Infectious Diseases Society of America Guidelines for Evaluating New Fever in Adult Patients in the ICU.
    O'Grady NP; Alexander E; Alhazzani W; Alshamsi F; Cuellar-Rodriguez J; Jefferson BK; Kalil AC; Pastores SM; Patel R; van Duin D; Weber DJ; Deresinski S
    Crit Care Med; 2023 Nov; 51(11):1570-1586. PubMed ID: 37902340
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Long-Term Outcomes and Risk of pancreatic cancer in Intraductal Papillary Mucinous Neoplasms.
    de la Fuente J; Chatterjee A; Lui J; Nehra AK; Bell MG; Lennon RJ; Kassmeyer BA; Graham RP; Nagayama H; Schulte PJ; Doering KA; Delgado AM; Vege SS; Chari ST; Takahashi N; Majumder S
    JAMA Netw Open; 2023 Oct; 6(10):e2337799. PubMed ID: 37847503
    [TBL] [Abstract] [Full Text] [Related]  

  • 9.
    Tobi M; Weinstein D; Kim M; Hatfield J; Sochacki P; Levi E; An T; Hamre M; Tolia V; Fligiel S; Marepally R; Hallman J; Bapat B; Yuan M; McVicker B; Gallinger S
    Curr Oncol; 2023 Aug; 30(9):7950-7963. PubMed ID: 37754493
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A blood-based metabolomic signature predictive of risk for pancreatic cancer.
    Irajizad E; Kenney A; Tang T; Vykoukal J; Wu R; Murage E; Dennison JB; Sans M; Long JP; Loftus M; Chabot JA; Kluger MD; Kastrinos F; Brais L; Babic A; Jajoo K; Lee LS; Clancy TE; Ng K; Bullock A; Genkinger JM; Maitra A; Do KA; Yu B; Wolpin BM; Hanash S; Fahrmann JF
    Cell Rep Med; 2023 Sep; 4(9):101194. PubMed ID: 37729870
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Mutation Analysis of pancreatic Juice and Plasma for the Detection of pancreatic cancer.
    Levink IJM; Jansen MPHM; Azmani Z; van IJcken W; van Marion R; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685923
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Association of emotional support with quality of life, mental health, and survival in older adults with gastrointestinal malignancies-Results from the CARE registry.
    Clausing D; Fowler ME; Harmon C; Tucker A; Outlaw D; Akce M; El-Rayes B; Giri S; Williams GR
    Cancer Med; 2023 Sep; 12(18):19102-19111. PubMed ID: 37644881
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The Evaluation of Gallstone Disease in the Year Before pancreatic cancer diagnosis.
    Papageorge MV; de Geus SWL; Woods AP; Ng SC; McAneny D; Tseng JF; Kenzik KM; Sachs TE
    J Surg Res; 2023 Nov; 291():282-288. PubMed ID: 37481963
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer.
    Babic A; Rosenthal MH; Sundaresan TK; Khalaf N; Lee V; Brais LK; Loftus M; Caplan L; Denning S; Gurung A; Harrod J; Schawkat K; Yuan C; Wang QL; Lee AA; Biller LH; Yurgelun MB; Ng K; Nowak JA; Aguirre AJ; Bhatia SN; Vander Heiden MG; Van Den Eeden SK; Caan BJ; Wolpin BM
    Nat Commun; 2023 Jul; 14(1):4317. PubMed ID: 37463915
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Early-Onset pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathology Features, and Oncological Outcomes.
    Pulvirenti A; Hauser HF; Fiedler LM; McIntyre CA; Le T; Reidy-Lagunes DL; Soares KC; Balachandran VP; Kingham TP; D'Angelica MI; Drebin JA; Jarnagin WR; Raj N; Wei AC
    Ann Surg; 2024 Jan; 279(1):125-131. PubMed ID: 37325926
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Germline Genetic Testing After cancer diagnosis.
    Kurian AW; Abrahamse P; Furgal A; Ward KC; Hamilton AS; Hodan R; Tocco R; Liu L; Berek JS; Hoang L; Yussuf A; Susswein L; Esplin ED; Slavin TP; Gomez SL; Hofer TP; Katz SJ
    JAMA; 2023 Jul; 330(1):43-51. PubMed ID: 37276540
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer.
    Reissig TM; Tzianopoulos I; Liffers ST; Rosery VK; Guyot M; Ting S; Wiesweg M; Kasper S; Meister P; Herold T; Schmidt HH; Schumacher B; Albers D; Markus P; Treckmann J; Schuler M; Schildhaus HU; Siveke JT
    ESMO Open; 2023 Jun; 8(3):101539. PubMed ID: 37148593
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Health Disparities in Presentation, Treatment, Genomic Testing, and Outcomes of pancreatic cancer in Hispanic and Non-Hispanic Patients.
    Halder R; Veeravelli S; Cheng C; Estrada-Mendizabal RJ; Recio-Boiles A
    J Racial Ethn Health Disparities; 2023 Dec; 10(6):3131-3139. PubMed ID: 37071331
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Under-Representation of Racial Groups in Genomics Studies of Gastroenteropancreatic Neuroendocrine Neoplasms.
    Herring BR; Bonner A; Guenter RE; Vickers S; Yates C; Lee G; Dhall D; Chen H; Rose JB
    Cancer Res Commun; 2022 Oct; 2(10):1162-1173. PubMed ID: 36969744
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. diagnosis and management of postpancreatectomy hemorrhage: A single-center experience of consecutive 1,096 pancreatoduodenectomies.
    Kobayashi K; Inoue Y; Omiya K; Sato S; Kato T; Oba A; Ono Y; Sato T; Ito H; Matsueda K; Saiura A; Takahashi Y
    Pancreatology; 2023 Apr; 23(3):235-244. PubMed ID: 36764874
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 20.